1. Home
  2. MTEM vs MIRA Comparison

MTEM vs MIRA Comparison

Compare MTEM & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEM
  • MIRA
  • Stock Information
  • Founded
  • MTEM N/A
  • MIRA 2020
  • Country
  • MTEM United States
  • MIRA United States
  • Employees
  • MTEM N/A
  • MIRA N/A
  • Industry
  • MTEM Biotechnology: Biological Products (No Diagnostic Substances)
  • MIRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEM Health Care
  • MIRA Health Care
  • Exchange
  • MTEM Nasdaq
  • MIRA Nasdaq
  • Market Cap
  • MTEM 8.5M
  • MIRA 10.2M
  • IPO Year
  • MTEM N/A
  • MIRA 2023
  • Fundamental
  • Price
  • MTEM $1.37
  • MIRA $2.36
  • Analyst Decision
  • MTEM
  • MIRA
  • Analyst Count
  • MTEM 0
  • MIRA 0
  • Target Price
  • MTEM N/A
  • MIRA N/A
  • AVG Volume (30 Days)
  • MTEM 18.0K
  • MIRA 11.4M
  • Earning Date
  • MTEM 08-08-2024
  • MIRA 09-13-2024
  • Dividend Yield
  • MTEM N/A
  • MIRA N/A
  • EPS Growth
  • MTEM N/A
  • MIRA N/A
  • EPS
  • MTEM N/A
  • MIRA N/A
  • Revenue
  • MTEM $31,763,000.00
  • MIRA N/A
  • Revenue This Year
  • MTEM N/A
  • MIRA N/A
  • Revenue Next Year
  • MTEM N/A
  • MIRA N/A
  • P/E Ratio
  • MTEM N/A
  • MIRA N/A
  • Revenue Growth
  • MTEM N/A
  • MIRA N/A
  • 52 Week Low
  • MTEM $1.01
  • MIRA $0.51
  • 52 Week High
  • MTEM $9.45
  • MIRA $6.95
  • Technical
  • Relative Strength Index (RSI)
  • MTEM 55.14
  • MIRA 59.37
  • Support Level
  • MTEM $1.26
  • MIRA $0.62
  • Resistance Level
  • MTEM $1.50
  • MIRA $5.01
  • Average True Range (ATR)
  • MTEM 0.11
  • MIRA 0.57
  • MACD
  • MTEM 0.01
  • MIRA 0.26
  • Stochastic Oscillator
  • MTEM 64.86
  • MIRA 41.07

About MTEM Molecular Templates Inc.

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: